These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3501241)
41. Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression. Hoitsma AJ; Wetzels JF; Berden JH; Koene RA Transplant Proc; 1988 Oct; 20(5 Suppl 6):12-3. PubMed ID: 3051578 [No Abstract] [Full Text] [Related]
42. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection. Orosz CG; Sirinek LP; Zinn NE; Ferguson RM Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303 [No Abstract] [Full Text] [Related]
43. Biological response modifiers in the treatment of noninfectious uveitis. Kopplin LJ; Shifera AS; Suhler EB; Lin P Int Ophthalmol Clin; 2015; 55(2):19-36. PubMed ID: 25730617 [No Abstract] [Full Text] [Related]
44. What determines the site of inflammation in uveitis and chorioretinitis? Forrester JV; Liversidge J; Dick A; McMenamin P; Kuppner M; Crane I; Hossain P Eye (Lond); 1997; 11 ( Pt 2)():162-6. PubMed ID: 9349406 [No Abstract] [Full Text] [Related]
45. [Treatment of posterior uveitis with cyclosporin or prednisolone--one-year report of a randomized prospective study]. Wiederholt M; Kämpe C; Hansen LL; Hövener G Fortschr Ophthalmol; 1986; 83(3):348-52. PubMed ID: 3527903 [No Abstract] [Full Text] [Related]
46. [Interleukin 2 production in S-antigen immunized rats and effects of cyclosporine]. Fujino Y; Okumura A; Nakamura M; Mochizuki M Nippon Ganka Gakkai Zasshi; 1986 Dec; 90(12):1646-52. PubMed ID: 3493642 [No Abstract] [Full Text] [Related]
47. [Significance and the course of cell-mediated response in uveitis]. Rusiecka-Ziółkowska J Przegl Lek; 2002; 59(2):113-4. PubMed ID: 12152247 [TBL] [Abstract][Full Text] [Related]
48. The effect of long-term cyclosporine therapy on natural killer cell activity. Versluis DJ; Metselaar HJ; Bijma AM; Vaessen LM; Wenting GJ; Weimar W Transplant Proc; 1988 Apr; 20(2 Suppl 2):179-85. PubMed ID: 3129839 [No Abstract] [Full Text] [Related]
49. Exacerbation of experimentally induced infection by cyclosporine A. Miller TE; Findon G Transplant Proc; 1988 Jun; 20(3 Suppl 3):913-9. PubMed ID: 3260419 [No Abstract] [Full Text] [Related]
51. Effects of cyclosporine and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats. Mochizuki M; Nussenblatt RB; Kuwabara T; Gery I Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):226-32. PubMed ID: 3871750 [TBL] [Abstract][Full Text] [Related]
52. [Diagnosis, immunopathogenesis, clinical picture and treatment of uveitis in nephropathies]. Teplinskaia LE; Kaliberdina AF Vestn Oftalmol; 2000; 116(5):39-42. PubMed ID: 11221380 [TBL] [Abstract][Full Text] [Related]
53. New biologic drugs: anti-interleukin therapy. Tappeiner C; Möller B; Hennig M; Heiligenhaus A Dev Ophthalmol; 2012; 51():79-89. PubMed ID: 22517206 [TBL] [Abstract][Full Text] [Related]
55. The use of immunosuppressive agents in diseases of the eye. O'Connor GR Trans New Orleans Acad Ophthalmol; 1983; 31():378-81. PubMed ID: 6401148 [No Abstract] [Full Text] [Related]
56. Toward understanding the mechanism of ciclosporin (cyclosporine) immunosuppression. Lorber MI Year Immunol; 1988; 3():291-302. PubMed ID: 3327316 [No Abstract] [Full Text] [Related]
59. Immunopathogenesis of LCM virus-induced uveitis: the role of T lymphocytes. Ticho U; Silverstein AM; Cole GA Invest Ophthalmol; 1974 Mar; 13(3):229-31. PubMed ID: 4591832 [No Abstract] [Full Text] [Related]
60. [Hyper-IGE reactions in uveitis and their immunomodulation with cytokine-containing agents]. Teplinskaia LE; Filichkina NS Vestn Oftalmol; 2006; 122(6):33-5. PubMed ID: 17217200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]